# Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT

> **NCT00586703** · PHASE1 · COMPLETED · sponsor: **David Rizzieri, MD** · enrollment: 21 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DEVICE:** NK-CD56

## Key facts

- **NCT ID:** NCT00586703
- **Lead sponsor:** David Rizzieri, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586703, "Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00586703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*